Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,087
Z1 Hip System: Post-Market Clinical Follow Up Study
for
Hip Osteoarthritis,
Location: Alexandria VA, Charlotte NC, Cleveland OH,
Sponsor: Zimmer Biomet
Sex: All
Age: 18+
Code: NCT07104279
Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Boston MA, New Haven CT, New York NY, Commack NY,
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
for
Metastatic Bone Disease
Location: Cincinnati OH, Fort Wayne IN, Aurora CO, Portland OR
Sponsor: Michelle Ghert, MD
Sex: All
Age: 18+
Code: NCT06863129
Recruiting
Food and Circadian Timing
for
Diet, High-Fat, Circadian Rhythm
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18 - 40
Code: NCT04743271
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
for
Prostate Cancer
Location: Boston MA, Atlanta GA, Austin TX, Portland OR
Sponsor: Blue Earth Diagnostics
Sex: Male
Age: 18+
Code: NCT07569926
Phase 4, Recruiting
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension, Interstitial Lung Disease
Location: New York NY, Philadelphia PA, Richmond VA, Durham NC,
Sponsor: Insmed Incorporated
Sex: All
Age: 18+
Code: NCT07179380
Phase 3, Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for
Non-Small Cell Lung Cancer
Location: Boston MA, Mineola NY, New York NY, Philadelphia PA,
Location: Boston MA, New York NY, Indianapolis IN, Aurora CO,
Sponsor: Oregon Health and Science University
Sex: All
Age: 18+
Code: NCT07282639
Recruiting
Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT
for
Thrombosis
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07498517
Phase 2, Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Cromwell CT, New York NY, Chapel Hill NC, Peterborough,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07783542
Phase 2, Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Boston MA, Quebec, Montreal, Plymouth Meeting PA,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
for
Higher-risk Myelodysplastic Syndrome
Location: The Bronx NY, New York NY, Hackensack NJ, Montreal,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06641414
Phase 3, Recruiting
Morning Bright Light to Improve Sleep Quality in Veterans